Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / COM
-
Number of holders
-
110
-
Total 13F shares, excl. options
-
31,836,157
-
Shares change
-
-3,195,685
-
Total reported value, excl. options
-
$271,100,301
-
Value change
-
-$43,426,928
-
Put/Call ratio
-
379%
-
Number of buys
-
56
-
Number of sells
-
-55
-
Price
-
$8.51
Significant Holders of TCR2 THERAPEUTICS INC - COM (TCRR) as of Q3 2021
141 filings reported holding TCRR - TCR2 THERAPEUTICS INC - COM as of Q3 2021.
TCR2 THERAPEUTICS INC - COM (TCRR) has 110 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 31,836,157 shares
.
Largest 10 shareholders include MPM ASSET MANAGEMENT LLC (4,050,865 shares), Redmile Group, LLC (3,816,709 shares), BioImpact Capital LLC (3,370,982 shares), BlackRock Inc. (2,964,553 shares), WELLINGTON MANAGEMENT GROUP LLP (2,745,176 shares), STATE STREET CORP (1,514,717 shares), VANGUARD GROUP INC (1,454,072 shares), ArrowMark Colorado Holdings LLC (1,213,498 shares), JPMORGAN CHASE & CO (1,030,360 shares), and Artal Group S.A. (750,000 shares).
This table shows the top 110 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.